Cognitive Neuroscience Market Analysis

  • Report ID: 3970
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Cognitive Neuroscience Market Analysis

Application (Brain Imaging, Neurological Research, Neurological Disorders, Psychiatry)

The neurological research segment in the cognitive neuroscience market is estimated to gain the largest revenue share of 40 % in the year 2036. The segment growth can be attributed to the growing investment in research in neuroscience including the development of new treatments, neurology devices, and diagnostic tools. Besides this, the availability of better treatments can be beneficial for both individuals and society. 

Type (Magnetic Resonance Imaging (MRI), Functional Magnetic Resonance Imaging, Positron Emission Tomography)

Cognitive neuroscience market from the functional magnetic resonance imaging (fMRI) segment is expected to garner a substantial share in the year 2036. The growth of the segment is attributed to the growing prevalence of brain stroke and Alzheimer’s. Both illnesses involve alterations in brain structure and function, necessitating the use of diagnostic imaging technologies such as fMRI. For instance, non-invasive imaging methods such as functional magnetic resonance imaging (fMRI) can be used to measure changes in blood flow to various parts of the brain.

Our in-depth analysis of the global cognitive neuroscience market includes the following segments:

          Type

  • Magnetic Resonance Imaging (MRI)
  • Functional Magnetic Resonance Imaging
  • Positron Emission Tomography

          Application

  • Brain Imaging
  • Neurological Research
  • Neurological Disorders
  • Psychiatry
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3970
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cognitive neuroscience is assessed at USD 38.39 Billion.

The cognitive neuroscience market size was valued at USD 36.24 Billion in 2023 and is projected to reach USD 83.19 Billion by the end of 2036, registering around 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of lifestyle disorders, increasing health spending are the major factors driving the market growth.

North America industry is anticipated to hold largest with a robust share of 35% by 2036, on account of growing cases of anxiety, and depression have resulted in an increased demand for cognitive neuroscience in the region.

Judges Scientific Plc., Alpha Omega Inc., Laserglow Technologies, Biobserve GmbH, Medtronic Plc, Abbot Laboratories, Pear Therapeutics, Inc., Interim HealthCare Inc., Stryker Corporation, Boston Scientific Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample